266.77BMarket Cap
19.97P/E TTM
After-hours 19:00 (ET)140.370USD-0.090-0.06%NVS Balance Sheet
You can check out the annual or quarterly balance sheets of Novartis AG here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing NVS stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Novartis AG Have?
In its most recent quarterly, Novartis AG had 7.62B in cash and cash equivalents.
How Much Are Novartis AG's Total Liabilities?
Novartis AG reported 64.40B in total liabilities as of the latest reported quarter, including 27.28B in current liabilities and 37.12B in non-current liabilities.
What Are Novartis AG's Total Assets?
As of the latest reported quarter, Novartis AG's total assets were 110.95B, consisting of 30.46B in current assets and 80.49B in non-current assets.
How Much Shareholders' Equity Does Novartis AG Have?
Novartis AG reported 46.55B in total shareholders' equity as of the latest reported quarter.